KALBE FARMA Tbk, PT Stock: price and insider trades · Indonesia
1 insider bought €2,005 of shares over the last 90 days, the latest by FERDINAND ARYANTO, filed 24 Aug 2026.
KALBE FARMA Tbk, PT: what insiders have been doing
Headquartered in Jakarta, Indonesia, KALBE FARMA Tbk, PT is a listed company and traces its origins to 1966. Filings by its managers are published through OJK / IDX. Over the twelve months to 8 November 2026, 2 filings were filed, from 2 insiders.
Every open-market trade in the period is a purchase: 2 purchases worth €2,041, from 2 insiders, and not a single sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Biggest ticket of the year: €2,005, bought by Ferdinand Aryanto and made public on 24 August 2026 (0.0001% of market cap). Those buying include 2 board members.
For context, the typical company on the same exchange (median of 245 companies) published 3 filings over the same period, against 2 filings here. Over the whole record (from 2026), the tally stands at 2 purchases and no sales.
The clock since the last published purchase (24 August 2026) now reads 76 days.
Every figure here comes from the filings published by OJK / IDX and describes the past, not future prices; it is not investment advice.
Who traded when
BuySaleSince the insiders bought
- -13.7%Entry IDR 805.00 · Close 16 Oct 2026 IDR 695.00
- -4.1%Entry IDR 725.00 · Close 16 Oct 2026 IDR 695.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate KALBE FARMA Tbk, PT Strong Buy (bullish), based on 17 analysts. Average price target: IDR 1,131.18.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 50,000 shares@ IDR 810.000.0001% mcap100.0% of flowCommon SharesIDXIDX:LK-24082026-0001-1#0Canonical exit: 19 Nov 2026 (T+90)
- 1,000 shares@ IDR 720.000.0000% mcap100.0% of flowCommon SharesIDXIDX:LK-10072026-0001-1#0Canonical exit: 7 Oct 2026 (T+90)
2 of 2 declarations
About KALBE FARMA Tbk, PT
KALBE FARMA Tbk, PT is an Indonesian pharmaceutical company specializing in the production of medicines, nutritional products, and health products. It is listed on the Indonesia Stock Exchange (XIDX).